deltatrials
Unknown OBSERVATIONAL NCT04671498

Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study

Detection by Circulating RNA With Optimized Machine Learning Technology for Breast Cancer: DROPLET-BC Study

Sponsor: M.D. Anderson Cancer Center

Conditions Breast Carcinoma
Interventions Biospecimen Collection Droplet-BC Test Electronic Health Record Review
Updated 8 times since 2021 Last updated: Jun 15, 2022 Started: Nov 3, 2020 Primary completion: Dec 31, 2022 Completion: Dec 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Carcinoma and is currently ongoing. M.D. Anderson Cancer Center leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~May 2021 · 3 months · monthly snapshotRecruiting~May 2021 – ~Sep 2021 · 4 months · monthly snapshotRecruiting~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshotRecruiting~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshotRecruiting~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Recruiting → Unknown

  3. Jul 2022 — Jul 2024 [monthly]

    Recruiting

  4. Dec 2021 — Jul 2022 [monthly]

    Recruiting

  5. Sep 2021 — Dec 2021 [monthly]

    Recruiting

▶ Show 3 earlier versions

  1. May 2021 — Sep 2021 [monthly]

    Recruiting

  2. Feb 2021 — May 2021 [monthly]

    Recruiting

  3. Jan 2021 — Feb 2021 [monthly]

    Recruiting

    First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • Preferred Medicine, Inc
Data source: Preferred Medicine, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations